Signal peptide mimicry primes Sec61 for client-selective inhibition
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Preventing the biogenesis of disease-relevant proteins is an attractive therapeutic strategy, but attempts to target essential protein biogenesis factors have been hampered by excessive toxicity. Here we describe KZR-8445, a cyclic depsipeptide that targets the Sec61 translocon and selectively disrupts secretory and membrane protein biogenesis in a signal peptide-dependent manner. KZR-8445 potently inhibits the secretion of pro-inflammatory cytokines in primary immune cells and is highly efficacious in a mouse model of rheumatoid arthritis. A cryogenic electron microscopy structure reveals that KZR-8445 occupies the fully opened Se61 lateral gate and blocks access to the lumenal plug domain. KZR-8445 binding stabilizes the lateral gate helices in a manner that traps select signal peptides in the Sec61 channel and prevents their movement into the lipid bilayer. Our results establish a framework for the structure-guided discovery of novel therapeutics that selectively modulate Sec61-mediated protein biogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925
Self-citationMolecular code for transmembrane-helix recognition by the Sec61 translocon.
Hessa, T., Meindl-Beinker, N. M., Bernsel, A., Kim, H., Sato, Y., Lerch-Bader, M., Nilsson, I., White, S. H., & von Heijne, G. (2007) · Nature · doi:10.1038/nature06387 · Cited by 708
Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004061 · Cited by 162 · cited 1×
“We also directly compared KZR-8445 to mycolactone A/B, a structurally distinct and relatively client-nonselective Sec61 inhibitor 8,23 , for their ability to discriminate between VCAM and preprolactin (pPL) signal peptides.”
Decatransin, a novel natural product inhibiting protein translocation at the Sec61/SecY translocon
Junne, T., Wong, J., Studer, C., Aust, T., Bauer, B. W., Beibel, M., Bhullar, B., Bruccoleri, R., Eichenberger, J., Estoppey, D., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.165746 · Cited by 67
Cited by
(2023) · doi:10.1126/sciadv.adf0797 · Cited by 38
Molecular view of ER membrane remodeling by the Sec61/TRAP translocon
Karki, S., Javanainen, M., Rehan, S., Tranter, D., Kellosalo, J., Huiskonen, J. T., Happonen, L., & Paavilainen, V. (2023) · The EMBO Reports · doi:10.15252/embr.202357910 · Cited by 25
Self-citationStructural analysis of the dynamic ribosome-translocon complex
Lewis, A. J., Zhong, F., Keenan, R. J., & Hegde, R. S. (2024) · eLife · doi:10.7554/elife.95814.3 · Cited by 9
Structural analysis of the dynamic ribosome-translocon complex
Lewis, A. J. O., Zhong, F., Keenan, R. J., & Hegde, R. S. (2023) · doi:10.1101/2023.12.22.572959
Metadata
- Authors
- Rehan, S., Tranter, D., Sharp, P. P., Craven, G. B., Lowe, E., Anderl, J. L., Muchamuel, T., Abrishami, V., Kuivanen, S., Wenzell, N. A., Jennings, A., Kalyanaraman, C., Strandin, T., Javanainen, M., Vapalahti, O., Jacobson, M. P., McMinn, D., Kirk, C. J., Huiskonen, J. T., Taunton, J., & Paavilainen, V. O.
- Venue
- Nature Chemical Biology
- Published
- 2023-05-11
- Volume
- 19
- Issue
- 9
- Pages
- 1054-1062
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W4376134511
- Cited by
- 38
- References
- 4
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Signal peptide mimicry primes Sec61 for client-selective inhibition. https://app.cochat.ai/papers/10.1038/s41589-023-01326-1
- The paper
- Rehan, S., Tranter, D., Sharp, P. P., Craven, G. B., Lowe, E., Anderl, J. L., Muchamuel, T., Abrishami, V., Kuivanen, S., Wenzell, N. A., Jennings, A., Kalyanaraman, C., Strandin, T., Javanainen, M., Vapalahti, O., Jacobson, M. P., McMinn, D., Kirk, C. J., Huiskonen, J. T., . . . Paavilainen, V. O. (2023). Signal peptide mimicry primes Sec61 for client-selective inhibition. Nature Chemical Biology. https://doi.org/10.1038/s41589-023-01326-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.